Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

When Edsger W. Dijkstra published his algorithm in 1959, computer networks were barely a thing. The algorithm in question found the shortest path between any two nodes on a graph, with a variant ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.

LinkedIn support accidentally revealed its algorithm: it tracks "viewer tolerance," reducing visibility for authors whose posts are consistently ignored. To succeed, diversify content types weekly, ...

Getting a handle on LeetCode can feel like a big task, especially when you’re starting out. But with the right approach and tools, it becomes much more manageable. Python, with its clear syntax and ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Facebook's vice president of product, Jagjit Chawla, talks about how the platform treats AI-generated content and how you can see less of it. Katelyn is a writer with CNET covering artificial ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. A preliminary TikTok deal proposes U.S. investors own 80% of its ...